Summary by Futu AI
HUALEN PHARMACEUTICAL-B (SHARE CODE: 2552) WILL HOLD ITS ANNUAL GENERAL MEETING AT ITS SHANGHAI HEADQUARTERS ON 27 JUNE 2024 TO DISCUSS THE RE-ELECTION OF RETIRING DIRECTORS, GRANTING GENERAL MANDATES TO REPURCHASE SHARES AND ISSUE SHARES, REAPPOINTMENT OF AUDITORS AND ADOPTION OF A NEW CHARTER AND RULES OF ORGANIZATION. If shareholders are unable to attend, a proxy form must be submitted 48 hours prior to the meeting. In addition, the Company also proposes to amend the Articles of Association to comply with the latest listing rules. The voting results of the General Meeting will be published as required on the Company's and HKEX's websites.